News & Events
< Back to News Overview
Sunshine Heart granted ethics approval from Royal Perth Hospital Sydney, Australia
03 / 08 / 2006
Sunshine Heart, Inc. (ASX: SHC) announced today that it has received ethics approval to commence its C-PulseTM clinical trial program at Royal Perth Hospital in Western Australia.
Royal Perth Hospital joins Auckland City Hospital in New Zealand, the Alfred Hospital and Southern Health Monash Medical Centre in Melbourne and St Vincent's Hospital in Sydney in Australia in the multi-centre pilot clinical trial of the C-PulseTM.
The clinical trial will investigate the safety of the C-PulseT and its ability to improve the heart function of patients with heart failure by increasing blood supply to the heart muscle and reducing the heart's pumping work. The CPulse T is uniquely designed as a non-blood contacting heart-assist device, reducing the risks of bleeding complications and making it safe to turn the
device on and off.
Royal Perth Hospital joins Auckland City Hospital in New Zealand, the Alfred Hospital and Southern Health Monash Medical Centre in Melbourne and St Vincent's Hospital in Sydney in Australia in the multi-centre pilot clinical trial of the C-PulseTM.
The clinical trial will investigate the safety of the C-PulseT and its ability to improve the heart function of patients with heart failure by increasing blood supply to the heart muscle and reducing the heart's pumping work. The CPulse T is uniquely designed as a non-blood contacting heart-assist device, reducing the risks of bleeding complications and making it safe to turn the
device on and off.